We're sorry but the Program doesn't work properly without JavaScript enabled. Please enable it to continue.
Horizontal
Vertical
List
Program
Chairs & Speakers
Favourites
Download Program
Help
Event Times (GMT+1)
Local Times (GMT+2)
Login
Session Groups
Session Types
Networking
Data Blitz Session
Spotlight Session
Symposium
Meet the Experts / Campfire Session
Plenary
Break
Session
Industry
Posters
Featured Communication
Rooms
Back
Kengo Yonezawa
Keio University School of Medicine, Tokyo, Japan
In presentations
Saturday, June 27, 10:15 AM – 10:15 AM
Feasibility of psilocybin treatment in Japanese patients with treatment-resistant depression: an open-label study
Speaker: Kengo Yonezawa (Keio University School of Medicine, Neuropsychiatry, Tokyo, Japan)